The establishment of 61medical in Queensland will be a great boost for the Medtech industry and help support the development and commercialisation of medtech breakthroughs. QUT partners with some of Australia's most innovative minds in health, science and biomedical engineering research. 61medical’s manufacturing capability and international network will enable their innovations to be brought to life. We look forward to a long and enduring partnership.
Professor Mark Harvey
Vice-President (Business Development), Division of Business Development, QUT
Bionics Queensland has forged close ties with 61medical and has proposed a close working partnership to fast track game changing innovations to help transform the lives of everyday Queenslanders living with disability.
Dr Dimity Dornan AO
Adjunct Associate Professor UQ, PhD UQ, HonDUniv USQ, BSpThy, FSPAA, FTSE, CpSp, LSLS Cert AVT
Executive Director and Founder, Hear and Say, and Founder and Chair, Bionics Queensland
61medical will have an extensive capacity for manufacturing medical devices, which is essential to fill the existing gap to bring our smart innovations into patient care in Queensland and Australia. This is an exciting keystone to make our research valuable for the trauma care of our patients.
Prof Michael Schuetz, FRACS
Director of the Jamieson Trauma Institute, Metro North Hospital and Health Service, Brisbane
Chair of Trauma, QUT
Australia punches above its weight in medical research but we need to be internationally competitive. For a small country we have so much innovative research that could lead to innovative products which can be sold on a global basis. 61medical will help bring our world best medical research to the world.
Prof Ian Frazer, AO
Faculty of Medicine, University of Queensland.
Chair, Australian Medical Research Advisory Board of the Medical Research Future Fund
